(Q82894553)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550299%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550299%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550299%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

F Atamaz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550299%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Hepguler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550299%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Akyildiz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550299%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Z Karasu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550299%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

21 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550299%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550299%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550299%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550299%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

942-949

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550299%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00198-006-0082-5

18 January 2020

exact match

0 references

cites work

Bone disease in liver transplant recipients: incidence, timing, and risk factors

1 reference

12 December 2020

The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients

1 reference

12 December 2020

Osteoporosis after organ transplantation

1 reference

12 December 2020

Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics

1 reference

12 December 2020

Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton

1 reference

12 December 2020

Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

1 reference

12 December 2020

Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study

1 reference

12 December 2020

Evidence of continuing bone recovery at a mean of 7 years after liver transplantation

1 reference

12 December 2020

Increased risk of fracture in patients receiving solid organ transplants

1 reference

12 December 2020

Osteoporosis in patients with organ transplants: a neglected problem

1 reference

12 December 2020

Bone loss after liver transplantation.

1 reference

12 December 2020

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

1 reference

12 December 2020

Osteoporosis screening in an outpatient liver transplant clinic: impact of primary immunosuppression

1 reference

12 December 2020

Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Mechanism of bone loss after liver transplantation: A histomorphometric analysis.

1 reference

12 December 2020

Predicting bone loss following orthotopic liver transplantation

1 reference

12 December 2020

Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol. The Liver Transplant Group, Groningen.

1 reference

12 December 2020

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

1 reference

12 December 2020

Vertebral fracture assessment using a semiquantitative technique.

1 reference

12 December 2020

Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.

1 reference

12 December 2020

Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.

1 reference

12 December 2020

Bone disease after liver transplantation

1 reference

12 December 2020

Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation

1 reference

12 December 2020

Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis

1 reference

12 December 2020

Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation.

1 reference

12 December 2020

Post-liver transplantation osteoporosis

1 reference

12 December 2020

Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup

1 reference

12 December 2020

Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures

1 reference

12 December 2020

A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis. The Alendronate Research Group

1 reference

12 December 2020

10.1007/S00198-006-0082-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16550299%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference